Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ketorolac versus tetracaine for analgesia and sedative requirement during phacoemulsification
IRCT20170716035104N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketorolac and tetracaine in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Need for midazolam, Need for propofol and 1 more. Started Mar 2017; status: completed.
02
Drugs
ketorolactetracaine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20170716035104N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170716035104N4.